A detailed history of Sugar Maple Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Sugar Maple Asset Management, LLC holds 17,000 shares of MRNA stock, worth $461,720. This represents 0.36% of its overall portfolio holdings.

Number of Shares
17,000
Holding current value
$461,720
% of portfolio
0.36%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

BUY
$23.51 - $34.67 $399,670 - $589,390
17,000 New
17,000 $439,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $10.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sugar Maple Asset Management, LLC Portfolio

Follow Sugar Maple Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sugar Maple Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sugar Maple Asset Management, LLC with notifications on news.